To determine whether CTLA4-chimera-transduced T cells (CTLA4-T) could specifically recognize and kill CD80-positive or CD86-positive tumor cells, we performed cytotoxicity assays by co-culturing CTLA4-T cells or genetically modified control T cells (GFP-T) with the tumor cells. The gene discussed is CTLA4; the disease is neoplasm.